AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Daclatasvir (Dihydrochloride)

9 registrations across 1 African market— 9 active

Markets with Daclatasvir (Dihydrochloride)

🌍WW
9 registrations
9 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
Daclatasvir (dihydrochloride) Tablet, Film-coated 60mg
Tablet, Film-coated
🌍WWHetero Labs Ltdactive
Daclatasvir (dihydrochloride) Tablet, Film-coated 60mg
Tablet, Film-coated
🌍WWMylan Laboratories Ltd.active
Daclatasvir (dihydrochloride) Tablet, Film-coated 30mg
Tablet, Film-coated
🌍WWLaurus Labs Limitedactive
Daclatasvir (dihydrochloride) Tablet, Film-coated 60mg
Tablet, Film-coated
🌍WWLaurus Labs Limitedactive
Daclatasvir (dihydrochloride) Tablet, Film-coated 30 mg
Tablet, Film-coated
🌍WWZydus Lifesciences Limitedactive
Daclatasvir (dihydrochloride) Tablet, Film-coated 60 mg
Tablet, Film-coated
🌍WWZydus Lifesciences Limitedactive
Daclatasvir (dihydrochloride) Tablet, Film-coated 30mg
Tablet, Film-coated
🌍WWHetero Labs Ltdactive
Daclatasvir (dihydrochloride)🌍WWMatrix Pharmacorp Private Limitedactive
Daclatasvir (dihydrochloride)🌍WWLaurus Labs Limitedactive

Daclatasvir (Dihydrochloride) in Africa — Regulatory Overview

Daclatasvir (Dihydrochloride) is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including WW. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.